4 ms·
> This isn't going to help India or anyone in the short term Why not? I’m not hearing a clear argument or evidence to support that withholding the patent recip
by beckman466 5y ago
> This isn't going to help India or anyone in the short term
Why not? I’m not hearing a clear argument or evidence to support that withholding the patent recipe wouldn’t save millions of lives?
India now has a very high number of cases. As it stands now, your argument just sounds to me like:
“yes human lives, but... profit“.
Please could you elaborate on your argument and/or provide examples of what you’re describing happening in other cases?
- janekm 5y agoSimple, the Indian vaccine factories already have licenses to produce these vaccines but are struggling to scale up production: https://www.bbc.co.uk/news/world-asia-india-55571793 https://www.bbc.co.uk/news/world-asia-india-55571793 (in part because they can't get some of the supplies needed, which maybe could be helped if the patents for those are also waived and other factories can help to make those...)
- deleted 5y ago[deleted]
- tobessebot 5y agohttps://blogs.sciencemag.org/pipeline/archives/2021/02/02/myths-of-vaccine-manufacturing https://blogs.sciencemag.org/pipeline/archives/2021/02/02/my... This is about mRNA vaccines, but similar things exist for viral vector vaccines as well. Technology transfer, bioreactor bags, fill-finish capacity, all of these things are bottlenecked till next year basically.